1. Home
  2. LNTH vs CBT Comparison

LNTH vs CBT Comparison

Compare LNTH & CBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • CBT
  • Stock Information
  • Founded
  • LNTH 1956
  • CBT 2019
  • Country
  • LNTH United States
  • CBT United States
  • Employees
  • LNTH N/A
  • CBT N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CBT Major Chemicals
  • Sector
  • LNTH Health Care
  • CBT Industrials
  • Exchange
  • LNTH Nasdaq
  • CBT Nasdaq
  • Market Cap
  • LNTH 3.8B
  • CBT 4.0B
  • IPO Year
  • LNTH 2015
  • CBT N/A
  • Fundamental
  • Price
  • LNTH $53.42
  • CBT $60.29
  • Analyst Decision
  • LNTH Buy
  • CBT Hold
  • Analyst Count
  • LNTH 6
  • CBT 3
  • Target Price
  • LNTH $74.17
  • CBT $74.00
  • AVG Volume (30 Days)
  • LNTH 1.3M
  • CBT 503.6K
  • Earning Date
  • LNTH 11-06-2025
  • CBT 11-03-2025
  • Dividend Yield
  • LNTH N/A
  • CBT 2.99%
  • EPS Growth
  • LNTH N/A
  • CBT N/A
  • EPS
  • LNTH 2.39
  • CBT 6.02
  • Revenue
  • LNTH $1,525,933,000.00
  • CBT $3,713,000,000.00
  • Revenue This Year
  • LNTH N/A
  • CBT $6.09
  • Revenue Next Year
  • LNTH $1.98
  • CBT $3.05
  • P/E Ratio
  • LNTH $22.36
  • CBT $10.01
  • Revenue Growth
  • LNTH 1.95
  • CBT N/A
  • 52 Week Low
  • LNTH $47.25
  • CBT $58.99
  • 52 Week High
  • LNTH $111.29
  • CBT $115.16
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 46.61
  • CBT 29.36
  • Support Level
  • LNTH $51.47
  • CBT $59.36
  • Resistance Level
  • LNTH $55.55
  • CBT $62.57
  • Average True Range (ATR)
  • LNTH 2.67
  • CBT 1.93
  • MACD
  • LNTH -0.30
  • CBT -0.05
  • Stochastic Oscillator
  • LNTH 28.53
  • CBT 13.05

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

Share on Social Networks: